138 related articles for article (PubMed ID: 33353395)
1. The development of a predictive risk model on post-ablation hemobilia: a multicenter matched case-control study.
Liu B; Li H; Guo J; Duan Y; Li C; Chen J; Zheng J; Li W
Br J Radiol; 2021 Feb; 94(1118):20200163. PubMed ID: 33353395
[TBL] [Abstract][Full Text] [Related]
2. Hemobilia after CT-guided radiofrequency ablation of liver tumors: frequency, risk factors, and clinical significance.
Hsieh MF; Chen CB; Chen YL; Chou CT
Abdom Radiol (NY); 2019 Jan; 44(1):337-345. PubMed ID: 29987402
[TBL] [Abstract][Full Text] [Related]
3. Ablation Volume Measurement After Percutaneous Cryoablation Using a Two-cryo-probe Technique for Small Hepatocellular Carcinomas.
Kim DK; Kwon JH; Won JY; Han K; Kim GM; Kim MD; Lee DY
Cardiovasc Intervent Radiol; 2019 Feb; 42(2):220-229. PubMed ID: 30288589
[TBL] [Abstract][Full Text] [Related]
4. Hemobilia after radiofrequency ablation of hepatocellular carcinoma.
Rhim H; Lim HK; Kim YS; Choi D; Lee KT
Abdom Imaging; 2007 Nov; 32(6):719-24. PubMed ID: 17171515
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablation.
Kawamura Y; Ikeda K; Seko Y; Hosaka T; Kobayashi M; Saitoh S; Kumada H
AJR Am J Roentgenol; 2011 Oct; 197(4):W665-73. PubMed ID: 21940538
[TBL] [Abstract][Full Text] [Related]
6. A case of hemocholecyst associated with hemobilia following radiofrequency ablation therapy for hepatocellular carcinoma.
Shin KY; Heo J; Kim JY; Lee SJ; Jang SY; Park SY; Jung MK; Cho CM; Tak WY; Kweon YO
Korean J Hepatol; 2011 Jun; 17(2):148-51. PubMed ID: 21757986
[TBL] [Abstract][Full Text] [Related]
7. A novel nomogram to predict the local tumor progression after microwave ablation in patients with early-stage hepatocellular carcinoma: A tool in prediction of successful ablation.
An C; Wu S; Huang Z; Ni J; Zuo M; Gu Y; Zhang T; Huang J
Cancer Med; 2020 Jan; 9(1):104-115. PubMed ID: 31714685
[TBL] [Abstract][Full Text] [Related]
8. Three-Dimensional Measurement of Hepatocellular Carcinoma Ablation Zones and Margins for Predicting Local Tumor Progression.
Hocquelet A; Trillaud H; Frulio N; Papadopoulos P; Balageas P; Salut C; Meyer M; Blanc JF; Montaudon M; Denis de Senneville B
J Vasc Interv Radiol; 2016 Jul; 27(7):1038-1045.e2. PubMed ID: 27156743
[TBL] [Abstract][Full Text] [Related]
9. Computed tomography follow-up for the detection of hepatocellular carcinoma recurrence after initial radiofrequency ablation: a single-center experience.
Mikami S; Tateishi R; Akahane M; Asaoka Y; Kondo Y; Goto T; Shiina S; Yoshida H; Koike K
J Vasc Interv Radiol; 2012 Oct; 23(10):1269-75. PubMed ID: 22999746
[TBL] [Abstract][Full Text] [Related]
10. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
Lee S; Rhim H; Kim YS; Kang TW; Song KD
Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
[TBL] [Abstract][Full Text] [Related]
11. Hepatic volumetry to predict adverse events in percutaneous ablation of hepatocellular carcinoma.
Hoshida Y; Shiratori Y; Koike Y; Obi S; Hamamura K; Teratani T; Shiina S; Omata M
Hepatogastroenterology; 2002; 49(44):451-5. PubMed ID: 11995472
[TBL] [Abstract][Full Text] [Related]
12. No-Touch Multi-bipolar Radiofrequency Ablation for the Treatment of Subcapsular Hepatocellular Carcinoma ≤ 5 cm Not Puncturable via the Non-tumorous Liver Parenchyma.
Petit A; Hocquelet A; N'kontchou G; Varin E; Sellier N; Seror O; Sutter O
Cardiovasc Intervent Radiol; 2020 Feb; 43(2):273-283. PubMed ID: 31673728
[TBL] [Abstract][Full Text] [Related]
13. Value of Nonrigid Registration of Pre-Procedure MR with Post-Procedure CT After Radiofrequency Ablation for Hepatocellular Carcinoma.
Park J; Lee JM; Lee DH; Joo I; Yoon JH; Park JY; Klotz E
Cardiovasc Intervent Radiol; 2017 Jun; 40(6):873-883. PubMed ID: 28091728
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of unresectable medium-large hepatocellular carcinoma nodules treated with radiofrequency ablation using a multiple-electrode switching system.
Francica G; Altiero M; Laccetti E; Pezzullo F; Tanga M; Avitabile G; Elameer M; Scaglione M
Br J Radiol; 2019 Jan; 92(1093):20180625. PubMed ID: 30272482
[TBL] [Abstract][Full Text] [Related]
15. Long-term Therapeutic Outcomes of Radiofrequency Ablation for Subcapsular versus Nonsubcapsular Hepatocellular Carcinoma: A Propensity Score Matched Study.
Kang TW; Lim HK; Lee MW; Kim YS; Rhim H; Lee WJ; Paik YH; Kim MJ; Ahn JH
Radiology; 2016 Jul; 280(1):300-12. PubMed ID: 26824711
[TBL] [Abstract][Full Text] [Related]
16. Secondary hemocholecyst after radiofrequency ablation therapy for hepatocellular carcinoma.
Yamamoto T; Kubo S; Hirohashi K; Tanaka S; Uenishi T; Ogawa M; Sakabe K; Hai S; Yamamoto S; Shuto T; Tanaka H; Kinoshita H
J Gastroenterol; 2003; 38(4):399-403. PubMed ID: 12743783
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of CT-guided percutaneous thermal ablation for hepatocellular carcinoma adjacent to the second porta hepatis.
Xie L; Cao F; Qi H; Song Z; Shen L; Chen S; Hu Y; Chen C; Fan W
Int J Hyperthermia; 2019; 36(1):1122-1128. PubMed ID: 31739695
[No Abstract] [Full Text] [Related]
18. Laparoscopic ablation therapies or hepatic resection in cirrhotic patients with small hepatocellular carcinoma.
Santambrogio R; Bruno S; Kluger MD; Costa M; Salceda J; Belli A; Laurent A; Barabino M; Opocher E; Azoulay D; Cherqui D
Dig Liver Dis; 2016 Feb; 48(2):189-96. PubMed ID: 26675381
[TBL] [Abstract][Full Text] [Related]
19. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.
Shiina S; Tateishi R; Arano T; Uchino K; Enooku K; Nakagawa H; Asaoka Y; Sato T; Masuzaki R; Kondo Y; Goto T; Yoshida H; Omata M; Koike K
Am J Gastroenterol; 2012 Apr; 107(4):569-77; quiz 578. PubMed ID: 22158026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
